AC IMMUNE SA Tax Expense Income At Applicable Tax Rate
AC IMMUNE SA (ACIU) reported Tax Expense Income At Applicable Tax Rate of -CHF 9.59 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate · last filed 2026-03-13
| Period end | Tax Expense Income At Applicable Tax Rate 12 month |
|---|---|
| 2025-12-31 | -9.59M CHF 20-F · filed 2026-03-13 |
| 2024-12-31 | -6.92M CHF 20-F · filed 2026-03-13 |
| 2023-12-31 | -7.37M CHF 20-F · filed 2026-03-13 |
| 2022-12-31 | -9.62M CHF 20-F · filed 2025-03-13 |
| 2021-12-31 | -9.93M CHF 20-F · filed 2024-03-14 |
| 2020-12-31 | -8.44M CHF 20-F · filed 2023-03-16 |
| 2019-12-31 | 6.19M CHF 20-F · filed 2022-03-22 |
| 2018-12-31 | -10.51M CHF 20-F · filed 2021-03-23 |
| 2017-12-31 | -5.42M CHF 20-F · filed 2020-03-30 |
| 2016-12-31 | -1.50M CHF 20-F · filed 2019-03-21 |
| 2015-12-31 | 4.57M CHF 20-F · filed 2018-03-20 |